new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Glaxosmithkline Llc
Glaxosmithkline Llcc
  

Glaxosmithkline Llc patents

Recent patent applications related to Glaxosmithkline Llc. Glaxosmithkline Llc is listed as an Agent/Assignee. Note: Glaxosmithkline Llc may have other listings under different names/spellings. We're not affiliated with Glaxosmithkline Llc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Glaxosmithkline Llc-related inventors




Date Glaxosmithkline Llc patents (updated weekly) - BOOKMARK this page
10/06/16Combination drug therapy
08/11/16Combination drug therapy
04/27/17 new patent  Benzimidazole derivatives as pi3 kinase inhibitors
04/06/17Enhancer of zeste homolog 2 inhibitors
03/23/17Novel compounds
03/23/17Novel compounds as diacylglycerol acyltransferase inhibitors
03/16/17Benzoxaborole compounds and uses thereof
02/02/17Novel compounds
01/05/17Novel crystalline forms of an antiviral benzimidazole compound
12/22/16Nicotinamide derivate in the treatment of acute coronary syndrome
11/03/164-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
10/20/16Metered dose container
10/20/16Treating cancer with a combination of a pd-1 antagonist and a vegfr inhibitor
10/13/16Indoles
10/13/16Thieno[3,2-c]pyridin-4(5h)-ones as bet inhibitors
10/13/16Prolyl hydroxylase inhibitors
10/06/16Combination drug therapy
09/15/16Combinations
09/08/16Novel compounds
09/08/16Novel process
08/11/166-amino-purin-8-one compounds
08/11/16Combination drug therapy
08/04/16Methods for determining total body skeletal muscle mass
05/05/16Derivatives of betulin
04/28/16Nicotine lozenge formulation
04/21/16Benzodiazepines for treating small cell lung cancer
04/21/16Combination therapies for cancer
04/07/16Pyrazolylaminopyridines as inhibitors of fak
04/07/16Methods for administering anti-il-5 antibodies
03/24/16Substituted bridged urea analogs as sirtuin modulators
03/10/16Novel compounds as diacylglycerol acyltransferase inhibitors
02/04/16Novel crystalline forms of an antiviral benzimidazole compound
01/28/16Pyrazolopyrimidine compounds
01/28/16Methods for administering hypoglycemic agents
01/21/16Host cells and methods of use
01/07/16Thieno[3,2-d]pyrimidine-6-carboxamides and analogues as sirtuin modulators
12/24/15Novel compounds
12/10/15Combination
11/19/15Novel pharmaceutical composition
11/12/15Therapeutic methods
11/12/15Novel compounds as diacylglycerol acyltransferase inhibitors
11/05/15Indoles
11/05/15Combination
11/05/15Pharmaceutical compositions
11/05/15Prolyl hydroxylase inhibitors
11/05/154-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
10/29/15Combination
10/29/15Enhancer of zeste homolog 2 inhibitors
10/22/15Novel compounds as diacylglycerol acyltransferase inhibitors
10/22/15Novel compounds
10/22/15Benzodiazepine bromodomain inhibitor
10/08/15Novel compounds
10/01/15Combination
10/01/15Combination
10/01/15Combination
09/24/15Pyrazolylaminopyridines as inhibitors of fak
09/24/15Novel compounds
09/03/15Benzimidazole derivatives as pi3 kinase inhibitors
08/27/15Quinolinone derivatives
08/27/15Benzodiazepines for treating small cell lung cancer
08/13/15Pyrazolopyrimidine compounds
08/06/15Method of adjuvant cancer treatment
08/06/15Derivatives of betulin
07/30/15Pharmaceutical compositions
07/30/15Nicotinamide derivate in the treatment of acute coronary syndrome
Patent Packs
07/30/15Benzodiazepine bromodomain inhibitor
07/23/15Container
07/09/15Treatment of cancers expressing p95 erbb2
07/09/15Vapor sheath for liquid dispensing nozzle
07/02/15Calcilytic compounds
06/25/15Nicotinamide riboside and analogues thereof
06/11/15Antibody formulations
06/11/15Using thermal imaging for control of a manufacturing process
06/11/15Using thermal imaging for control of a manufacturing process
06/04/15Inhibitors of akt activity
06/04/15Substituted bridged urea analogs as sirtuin modulators
05/28/15Method of treating cancer with megea3 immunotherapeutic with braf inhibitor and/or mek inhibitor
05/28/15Chromenone analogs as sirtuin modulators
05/21/15Indoles
05/14/15Bromodomain inhibitors for treating autoimmune and inflammatory diseases
Patent Packs
05/07/15Enhancer of zeste homolog 2 inhibitors
04/30/15Combination
04/23/15Novel antibodies
04/23/15Pharmaceutical combination of mek inhibitor and b-raf inhibitors
04/16/15Nicotine lozenge composition
04/02/15Thrombopoietin mimetics
04/02/15Combination
04/02/15Combination
03/19/153'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
03/19/15Benzoxaborole compounds and uses thereof
03/19/15Novel compounds
03/12/15Combination
03/05/15Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
02/26/15Benzimidazoles and related analogs as sirtuin modulators
02/12/15Crystalline n--5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
01/29/15Continuous coating of pellets
01/08/15Medical product dispensing systems and methods
01/01/15External nasal dilator and methods
12/25/14Benzimidazole derivatives as pi3 kinase inhibitors
12/25/14Methods of treating cancer
11/20/14Azaindazoles
11/13/14Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
09/25/14Composition
09/18/14Cancer treatment method
09/04/14Compounds and methods for enhancing innate immune responses
09/04/14Treatment of blood lipid abnormalities and other conditions
09/04/14Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
08/21/14Combination treatments for hepatitis c
08/14/14Pharmaceutical compositions
08/14/14Pharmaceutical compositions
Social Network Patent Pack
07/03/14Pyrazolopyrimidine derivatives as pi3 kinase inhibitors
07/03/14Pharmaceutical combination of mek inhibitor and b-raf inhibitors
06/19/14Protein purification
06/05/14Pyrazolylaminopyridines as inhibitors of fak
05/29/14Novel compounds as diacylglycerol acyltransferase inhibitors
05/22/14Method of treating thrombocytopenia
05/22/14Benzimidazole derivatives as pi3 kinase inhibitors
04/24/14Trpv4 antagonists
04/17/14Pyrazolylaminopyridines as inhibitors of fak
04/10/14Triazolones as fatty acid synthase inhibitors
Patent Packs
04/10/14Quinoline derivatives as pi3 kinase inhibitors
04/10/14Novel compounds as antagonists or inverse agonists at opioid receptors
04/10/14Methods for treating degenerative diseases/injuries
03/20/14Benzene sulfonamide thiazole and oxazole compounds
03/20/14Statin and omega-3 fatty acids for lipid therapy
03/13/14Crystalline n--5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
03/06/14Tetrahydroquinoline derivatives useful as bromodomain inhibitors
03/06/14Sustained release paracetamol formulations
03/06/14Novel method
02/27/14Novel compounds
02/27/14Calcilytic compounds
02/13/14Lyophilized formulations
02/13/14Formulations with reduced viscosity
02/13/147-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1h-imidazo[4,5-c]quinoline derivatives
02/06/143'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
02/06/14Novel pharmaceutical composition
02/06/14Cancer treatment method
02/06/14Tetrahydroquinoline derivatives useful as bromodomain inhibitors
02/06/14Antacid tablet
01/30/14Tetrahydroquinoline derivatives useful as bromodomain inhibitors
01/23/14Formulations with reduced viscosity
01/23/14Novel adenine derivatives
01/23/14Prolyl hydroxylase inhibitors
01/16/14Buffer system for protein purification
01/16/14Benzimidazole derivatives as pi3 kinase inhibitors
12/26/13Peptide deformylase inhibitors
12/26/13Indoles
12/26/13Quinolinone derivatives
12/26/131h-pyrollo[3,2-d]pyrimidinedione derivatives
11/21/13Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
Patent Packs
10/31/13Combination
10/31/13Nicotine lozenge composition
09/05/13Methods for administering hypoglycemic agents
09/05/13Inhibitors of akt activity
08/29/13Methods for administering hypoglycemic agents
08/01/13Benzimidazole derivatives as pi3 kinase inhibitors
07/18/13Derivatives of betulin
07/04/13Combination of braf and vegf inhibitors
06/20/13Benzimidazole boronic acid derivatives as pi3 kinase inhibitors
06/20/13Calcilytic compounds
06/13/13Novel compounds
06/06/13Benzene sulfonamide thiazole and oxazole compounds
05/30/13Methods for treating degenerative diseases/injuries
03/28/13Thrombopoietin mimetics
03/21/13Prolyl hydroxylase inhibitors
03/21/13Combination
03/21/13Chemical compounds
02/28/13Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection
02/28/13Indazoles
02/28/13Pyrrolo [3,2-d] pyrimidin-3-yl derivatives used as activators of ampk
Social Network Patent Pack
02/07/13Process for preparing benzoxaboroles
01/31/13Chemical compounds
01/17/13Azaindole compounds and methods for treating hiv
01/10/13Trpv4 antagonists
12/13/12Novel uses
12/13/12Purine derivatives and their pharmaceutical uses
12/06/126-amino-2--9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
11/29/12Cancer treatment method
11/22/12Cancer treatment method
11/08/12Combination
11/08/12Compounds
09/27/12Coating for latex articles
09/27/12Combination
09/20/121h-pyrrolo[2,3-b]pyridines
08/16/12Benzimidazoles as fatty acid synthase inhibitors
08/09/12Combination
08/02/12Combination
07/26/123'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
07/05/12Pyrrolo-pyridine derivatives as activators of ampk
07/05/12Improved external nasal dilator
Social Network Patent Pack
03/22/12Methods for identifying compounds of interest using encoded libraries
03/22/12Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/08/12Using thermal imaging for control of a manufacturing process
03/01/12Method of treating thrombocytopenia
02/16/12Indole carboxamides as ikk2 inhibitors
02/09/126-amino-purin-8-one compounds
01/12/12Indole derivatives as ikk2 inhibitors
12/08/11Chemical compounds
11/03/11Compounds
10/27/11Processes and intermediates for carbamoylpyridone hiv integrase inhibitors
09/22/11Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
09/01/11Thrombopoietin mimetics
08/04/11Chemical compounds
06/23/11Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol
06/23/11Chemical compounds
06/16/11Novel adenine derivatives
06/09/11Process
06/09/11Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
06/09/11Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
06/09/11Trisubstituted boron-containing molecules
04/21/11Inhibitors of akt activity
04/07/113'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
03/03/11Compounds and methods of treatment
03/03/11Calcilytic compounds
03/03/11External nasal dilator and methods of manufacture
02/24/112,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
01/27/11Antibody formulations
01/27/11Methods of treatment
01/13/11Method and electronically modeling and manufacturing dentures
01/13/11Novel compounds
Social Network Patent Pack
12/23/10Apparatus and manufacturing customized dentures
12/16/10Method and predicting properties of granulated materials and dosage forms made therefrom
12/09/10Pyridosulfonamide derivatives as p13 kinase inhibitors
12/02/10Prolyl hydroxylase inhibitors
11/11/10Combinatory analytical strip
10/14/10Novel seh inhibitors and their use
09/30/10Novel seh inhibitors and their use
08/26/10Chemical compounds
08/26/10Imidazopyridine kinase inhibitors
08/12/10Pyridopyrimidine derivatives as p13 kinase inhibitors
08/05/10Compounds
06/17/10Pyridine derivatives and their use in the treatment of psychotic disorders







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glaxosmithkline Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glaxosmithkline Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';